Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Anticancer Research · 2024
DOI: 10.21873/anticanres.16806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Takashi Nakanishi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Neutrophils, Rectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
- Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan; takerumatsuda@nifty.com.
- Division of Minimally Invasive Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Zitieren
APA
Nakanishi, T., Matsuda, T., Yamashita, K., Hasegawa, H., Sawada, R., Harada, H., Urakawa, N., Goto, H., Kanaji, S., Oshikiri, T., & Kakeji, Y. (2024). Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy. Anticancer Research. https://doi.org/10.21873/anticanres.16806
Vancouver
Nakanishi T, Matsuda T, Yamashita K, Hasegawa H, Sawada R, Harada H, et al. Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy. Anticancer Research. 2024. doi:10.21873/anticanres.16806
BibTeX
@article{Nakanishi2024,
author = {Nakanishi, Takashi and Matsuda, Takeru and Yamashita, Kimihiro and Hasegawa, Hiroshi and Sawada, Ryuichiro and Harada, Hitoshi and Urakawa, Naoki and Goto, Hironobu and Kanaji, Shingo and Oshikiri, Taro and Kakeji, Yoshihiro},
title = {Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16806}
}
EUVIMED